首页> 外文期刊>Journal of medical systems >Cerberus, an Access Control Scheme for Enforcing Least Privilege in Patient Cohort Study Platforms A Comprehensive Access Control Scheme Applied to the GENIDA Project - Study of Genetic Forms of Intellectual Disabilities and Autism Spectrum Disorders
【24h】

Cerberus, an Access Control Scheme for Enforcing Least Privilege in Patient Cohort Study Platforms A Comprehensive Access Control Scheme Applied to the GENIDA Project - Study of Genetic Forms of Intellectual Disabilities and Autism Spectrum Disorders

机译:CERBERUS,一种用于在患者队列研究平台中执行最不特权的访问控制方案,应用于GENIDA项目的综合性访问控制方案 - 智力疾病遗传形式和自闭症谱系统的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Cohort Study Platforms (CSP) are emerging as a key tool for collecting patient information, providing new research data, and supporting family and patient associations. However they pose new ethics and regulatory challenges since they cross the gap between patients and medical practitioners. One of the critical issues for CSP is to enforce a strict control on access privileges whilst allowing the users to take advantage of the breadth of the available data. We propose Cerberus, a new access control scheme spanning the whole life-cycle of access right management: design, implementation, deployment and maintenance, operations. Cerberus enables switching from a dual world, where CSP data can be accessed either from the users who entered it or fully de-identified, to an access-when-required world, where patients, practitioners and researchers can access focused medical data through explicit authorisation by the data owner. Efficient access control requires application-specific access rights, as well as the ability to restrict these rights when they are not used. Cerberus is implemented and evaluated in the context of the GENIDA project, an international CSP for Genetically determined Intellectual Disabilities and Autism Spectrum Disorders. As a result of this study, the software is made available for the community, and validated specifications for CSPs are given.
机译:队列研究平台(CSP)是作为收集患者信息的关键工具,提供新的研究数据和支持家庭和患者协会。然而,他们构成了新的道德和监管挑战,因为它们跨越患者和医学从业者之间的差距。 CSP的关键问题之一是在允许用户利用可用数据的广度的情况下执行对访问权限的严格控制。我们提出了Cerberus,这是一个新的访问控制方案,跨越进入权限管理的整个生命周期:设计,实施,部署和维护,操作。 Cerberus能够从Dual World切换,其中CSP数据可以从进入它或完全取消识别的用户访问到访问 - 当前世界,从业者,从业者和研究人员通过明确授权访问聚焦的医疗数据由数据所有者。高效的访问控制需要特定于应用程序的访问权限,以及在未使用时限制这些权限的能力。在Genida项目的背景下实施和评估了Cerberus,这是一个用于转基因智力障碍和自闭症谱系统的国际CSP。由于本研究,该软件可用于社区,并给出了CSP的验证规范。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号